Cargando…
Fulminant myocarditis after the first dose of mRNA-1273 vaccination in a patient with previous COVID-19: a case report
BACKGROUND: COVID-19 vaccines have shown success in protecting people worldwide, although serious adverse effects have been reported in very rare cases. CASE SUMMARY: A 32-year-old male with a prior medical history of mild COVID-19 infection developed fulminant myocarditis five days after mRNA-1273...
Autores principales: | Horiuchi, Kohei, Kosugi, Shumpei, Abe, Haruhiko, Ueda, Yasunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278249/ https://www.ncbi.nlm.nih.gov/pubmed/35860438 http://dx.doi.org/10.1093/ehjcr/ytac290 |
Ejemplares similares
-
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273
Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022) -
mRNA-1273: Myocarditis: case report
Publicado: (2021) -
Myocarditis following COVID‐19 mRNA (mRNA‐1273) vaccination
por: Chellapandian, Suresh Babu, et al.
Publicado: (2022) -
Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023) -
Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)